Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $322.68 | $7.06 | 4,467.58% | 6,453.60x | 227.06x | 7.15x | 8.66x | 17.39x | $529.27M | 1.49% | $4.13B | 37.48 | $33.61B | 105.69 | ||
| CORT | CORCEPT THERAPEUTICS INC | $85.31 | $29.27 | 191.48% | 85.31x | 83.47x | 11.92x | 14.20x | 1.32x | $162.57M | 1.84% | $631.90M | 6.10 | $8.85B | 134.21 | ||
| NVO | NOVO NORDISK A S | $49.05 | $141.33 | -65.30% | 13.64x | 2.06x | 4.48x | 8.33x | 0.15x | $9.34B | 4.29% | $26.18B | 5.89 | $228.61B | 9.21 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $404.46 | $29.37 | 1,276.93% | 1,304.71x | 216.03x | 16.56x | 228.46x | 5.35x | $221.36M | 0.42% | $233.89M | 1.78 | $55.16B | 363.06 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.45 | $11.61 | -27.22% | 17.60x | 6.47x | 5.60x | 3.57x | 0.35x | -$23.64M | -5.01% | $133.17M | 2.38 | $483.99M | 7.20 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $40.55 | $14.77 | 174.49% | 82.74x | 40.63x | 5.07x | 5.74x | 1.24x | $101.73M | 3.36% | $535.38M | 7.17 | $2.91B | 54.28 | ||
| GMAB | GENMAB A | $31.24 | $107.91 | -71.05% | 13.33x | 1.74x | 5.63x | 3.49x | 0.12x | $1.19B | 5.95% | $5.75B | 8.96 | $18.44B | 9.22 | ||
| ARGX | ARGENX SE | $890.11 | $275.62 | 222.95% | 35.57x | 49.48x | 28,713.23x | 7.58x | 2.46x | $467.72M | 0.86% | $7.17B | 117.50 | $51.92B | 64.00 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $184.03 | $64.42 | 185.66% | 79.67x | 23.87x | 14.34x | 3.81x | 1.31x | $30.76M | 0.85% | $950.17M | 48.53 | $3.93B | 38.19 | ||
| VCEL | VERICEL CORP | $37.64 | $6.60 | 470.46% | 144.77x | 137.32x | 7.35x | 5.91x | 2.69x | $20.38M | 1.07% | $321.86M | 6.38 | $1.90B | 64.86 | ||
| TECH | BIO-TECHNE CORP | $60.83 | $16.27 | 273.98% | 121.66x | 30.09x | 7.77x | 4.82x | 1.66x | $224.06M | 2.37% | $1.97B | 12.65 | $9.73B | 44.04 | ||
| RPRX | ROYALTY PHARMA PLC | $38.26 | $42.08 | -9.08% | 21.74x | 7.95x | 7.03x | 2.30x | 0.44x | $2.11B | 12.78% | $9.62B | 22.28 | $30.09B | 28.82 | ||
| KRYS | KRYSTAL BIOTECH INC | $239.72 | $67.25 | 256.47% | 34.74x | 38.37x | 18.60x | 6.11x | 3.16x | $166.02M | 2.39% | $1.14B | 39.30 | $6.57B | 33.98 | ||
| VCYT | VERACYTE INC | $43.33 | $9.16 | 372.84% | 111.10x | 82.75x | 6.89x | 2.72x | 2.28x | $98.21M | 2.88% | $1.26B | 15.98 | $3.15B | 55.24 | ||
| CRMD | CORMEDIX INC | $11.47 | $13.16 | -12.84% | 5.05x | 4.58x | 4.06x | 2.42x | 26.28x | $74.42M | 8.54% | $374.13M | 4.93 | $1.00B | 8.94 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.47 | $7.69 | 101.09% | 26.67x | 20.38x | 7.67x | 5.58x | 1.29x | $119.87M | 5.88% | $365.77M | 2.78 | $2.04B | 19.75 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $53.70 | $41.59 | 29.11% | 19.74x | 18.15x | 3.33x | 1.70x | 0.75x | $832.13M | 8.07% | $6.06B | 31.54 | $9.66B | 12.51 | ||
| HALO | HALOZYME THERAPEUTICS INC | $62.65 | $74.69 | -16.12% | 12.81x | 9.79x | 5.91x | 14.62x | 0.49x | $602.40M | 8.20% | $503.92M | 4.30 | $8.46B | 10.00 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.80 | $1.29 | 39.18% | 25.71x | 71.15x | 2.31x | 2.74x | 0.74x | -$11.69M | -8.17% | $52.91M | 0.67 | $139.29M | 15.70 | ||
| GYRE | GYRE THERAPEUTICS INC | $8.46 | $0.75 | 1,029.34% | 120.86x | 55.29x | 7.16x | 8.00x | 8.87x | $3.05M | 0.40% | $101.92M | 1.12 | $775.74M | 58.64 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.27 | $36.60 | 7.28% | 12.16x | 12.05x | 2.74x | 2.71x | 0.79x | $296.89M | 13.14% | $835.12M | 14.51 | $1.78B | 6.61 | ||
| EXEL | EXELIXIS INC | $41.07 | $29.00 | 41.62% | 16.70x | 15.88x | 4.82x | 5.10x | 1.01x | $779.77M | 7.07% | $2.16B | 8.05 | $10.81B | 11.66 | ||
| MNKD | MANNKIND CORP | $5.84 | $1.43 | 309.73% | 58.40x | 73.37x | 5.71x | -40.25x | 2.50x | $43.39M | 2.41% | -$44.55M | -0.15 | $2.03B | 27.68 | ||
| INCY | INCYTE CORP | $95.17 | $67.53 | 40.94% | 15.76x | 13.64x | 3.87x | 4.02x | 1.06x | $1.20B | 6.43% | $4.65B | 23.77 | $16.26B | 9.67 | ||
| INVA | INNOVIVA INC | $20.62 | $15.28 | 34.99% | 10.91x | 9.63x | 3.67x | 1.53x | 1.69x | $196.54M | 13.80% | $1.01B | 14.63 | $1.32B | 6.16 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $444.64 | $168.69 | 163.58% | 31.07x | 23.80x | 9.69x | 6.51x | 1.87x | $3.34B | 2.94% | $17.32B | 67.76 | $109.71B | 23.53 | ||
| ADMA | ADMA BIOLOGICS INC | $19.98 | $9.29 | 115.03% | 22.70x | 33.39x | 9.76x | 11.03x | 1.72x | $40.73M | 0.86% | $431.19M | 1.81 | $4.77B | 27.70 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.58 | $3.30 | 99.45% | 24.37x | 35.45x | 4.21x | 7.43x | 1.37x | $21.15M | 4.03% | $70.68M | 0.89 | $463.89M | 20.44 | ||
| UTHR | UNITED THERAPEUTICS CORP | $484.86 | $198.67 | 144.06% | 17.02x | 17.56x | 6.79x | 3.17x | 4.98x | $1.12B | 5.28% | $6.59B | 150.46 | $19.54B | 11.02 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $22.80 | $12.61 | 80.78% | 12.74x | 14.51x | 4.83x | 3.05x | 3.53x | $234.54M | 8.39% | $920.25M | 7.51 | $2.11B | 6.53 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $726.21 | $356.11 | 103.93% | 16.71x | 16.52x | 5.28x | 2.47x | 2.47x | $4.22B | 5.61% | $30.96B | 298.82 | $76.52B | 13.40 | ||
| MDXG | MIMEDX GROUP INC | $6.98 | $2.76 | 153.33% | 24.93x | 16.29x | 2.63x | 4.33x | 2.21x | $66.82M | 6.46% | $238.95M | 1.61 | $909.88M | 13.15 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.